Clinical outcomes and tumor immune microenvironment in SMARCA4-Deficient NSCLC: A Real-World retrospective study
{{output}}
Background: SMARCA4-deficient thoracic tumors constitute a rare and aggressive form of lung cancer characterized by a dismal prognosis. This research investigates the clinical features, treatment outcomes, and characteristics of ... ...
